We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$437M
AUM Growth
+$30.2M
Cap. Flow
+$3.43M
Cap. Flow %
0.78%
Top 10 Hldgs %
24.44%
Holding
187
New
7
Increased
67
Reduced
70
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.88M
2
IBM icon
IBM
IBM
+$2.54M
3
GE icon
GE Aerospace
GE
+$1.57M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$846K
5
UNH icon
UnitedHealth
UNH
+$594K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.28M
2
NVS icon
Novartis
NVS
+$2.2M
3
BA icon
Boeing
BA
+$1.69M
4
PFE icon
Pfizer
PFE
+$1.27M
5
AAPL icon
Apple
AAPL
+$529K

Sector Composition

Rank Sector Weight
1 Financials 15.2%
2 Technology 13.51%
3 Healthcare 13.47%
4 Consumer Discretionary 11.17%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$20.8M 4.75%
490,960
-12,652
-3% -$529K
JPM icon
2
JPMorgan Chase
JPM
$907B
$12.1M 2.77%
112,970
-2,119
-2% -$215K
PG icon
3
Procter & Gamble
PG
$349B
$10.8M 2.47%
117,683
+2,272
+2% +$204K
HD icon
4
Home Depot
HD
$338B
$10M 2.3%
52,914
-2,274
-4% -$392K
IVV icon
5
iShares Core S&P 500 ETF
IVV
$881B
$9.61M 2.2%
35,756
+3,230
+10% +$846K
MSFT icon
6
Microsoft
MSFT
$2.93T
$9.59M 2.19%
112,073
-2,572
-2% -$211K
V icon
7
Visa
V
$682B
$8.94M 2.05%
78,429
-3,080
-4% -$340K
BLK icon
8
Blackrock
BLK
$166B
$8.4M 1.92%
16,352
-826
-5% -$402K
ABBV icon
9
AbbVie
ABBV
$450B
$8.4M 1.92%
86,843
-24,142
-22% -$2.28M
HON icon
10
Honeywell
HON
$71.3B
$8.14M 1.86%
58,776
-1,437
-2% -$193K
BA icon
11
Boeing
BA
$169B
$7.87M 1.8%
26,678
-6,246
-19% -$1.69M
TFC icon
12
Truist Financial
TFC
$65.4B
$7.45M 1.7%
149,755
+3,433
+2% +$166K
JNJ icon
13
Johnson & Johnson
JNJ
$609B
$7.37M 1.69%
52,767
-644
-1% -$89.7K
KO icon
14
Coca-Cola
KO
$351B
$7.28M 1.67%
158,590
+5,809
+4% +$267K
NKE icon
15
Nike
NKE
$64.9B
$7.27M 1.66%
116,232
+2,619
+2% +$151K
DIS icon
16
Walt Disney
DIS
$170B
$7.18M 1.64%
66,784
+1,170
+2% +$121K
TMO icon
17
Thermo Fisher Scientific
TMO
$198B
$6.94M 1.59%
36,556
-595
-2% -$114K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.23T
$6.71M 1.54%
127,500
-700
-0.5% -$36.1K
COP icon
19
ConocoPhillips
COP
$140B
$6M 1.37%
109,265
+1,805
+2% +$92.8K
META icon
20
Meta Platforms (Facebook)
META
$1.64T
$5.98M 1.37%
33,905
-1,320
-4% -$233K
XOM icon
21
ExxonMobil
XOM
$611B
$5.93M 1.36%
70,862
+218
+0.3% +$18K
MCD icon
22
McDonald's
MCD
$190B
$5.58M 1.28%
32,437
-1,019
-3% -$171K
MDT icon
23
Medtronic
MDT
$106B
$5.57M 1.27%
68,926
+60,882
+757% +$4.88M
GILD icon
24
Gilead Sciences
GILD
$167B
$5.46M 1.25%
76,288
+1,010
+1% +$76.7K
GE icon
25
GE Aerospace
GE
$364B
$5.46M 1.25%
65,232
+16,492
+34% +$1.57M

Similar funds

Stonebridge Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Stonebridge Capital Advisors held 187 positions worth $437M, up 7.4% from $407M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors's Q4 2017 filing shows 7 new, 67 increased, 70 reduced and 10 closed positions. Its largest new stake was Caterpillar: 1,734 shares worth $273K. The largest sale was AbbVie, an estimated $2.28M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Stonebridge Capital Advisors's largest Q4 2017 buy was Caterpillar: 1,734 shares worth $273K.
  • Stonebridge Capital Advisors added most to Medtronic in Q4 2017, an estimated $4.88M increase.
  • Stonebridge Capital Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $2.28M.
  • Stonebridge Capital Advisors fully exited Novartis in Q4 2017, selling an estimated $2.2M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $437M portfolio in Q4 2017.
  • Stonebridge Capital Advisors opened 7 new positions and closed 10 in Q4 2017.
  • Stonebridge Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $437M.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2017, filed 15 Feb 2018.